Welcome to MAKScientific

" MAKScientific is dedicated to discovering and developing novel medications for "therapeutic indications in the areas of pain, obesity, neuroprotection and other "unmet medical needs. "

Company Overview

MAKScientific, LLC, is a privately held Connecticut-based company founded in 2004 on the basis of research conducted by a leader in the field of cannabinoids. Our mission is the discovery, development and commercialization of novel therapeutics in the areas of neuropathic, inflammatory and somatic pain, obesity, neuroprotection, and addiction and glaucoma.

MAKScientific is a leader in endocannabinoid research with the ability to address major unmet medical needs for selected diseases with clear competitive advantage over present therapies. The Company holds a proprietary understanding of the endocannabinoid biochemical pathways and has validated therapeutic targets. The Company’s proficiency in medicinal chemistry, and molecular biology is dedicated to the human cannabinoid system including the CB1 and CB2 receptors, as well as enzymes and transporters that modulate the endocannabinoid system. Our goal is the development of potent and selective cannabinergic compounds (agonists and antagonists) for use as novel medications. The Company has substantial drug development assets that include (i) a large library of over 5,000 potent and highly selective cannabinergic compounds that can potentially lead to the development of novel medications, (ii) validated targets for therapeutic drug development and (iii) a proprietary understanding of the endocannabinoid pathways.